Infinitt Healthcare Co., Ltd

As of March 31, 2026, Infinitt Healthcare Co., Ltd carries a market capitalization of 145.28B, placing it among publicly traded companies globally. Its enterprise value stands at -42.10B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Infinitt Healthcare Co., Ltd has 24.38M shares outstanding.

As of March 31, 2026, Infinitt Healthcare Co., Ltd trades at a trailing price-to-earnings ratio of 3.57. The price-to-sales ratio is 1.32, and the price-to-book ratio stands at 0.72.

As of March 31, 2026, Infinitt Healthcare Co., Ltd maintains a current ratio of 5.72, meaning it holds 5.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.24, indicating moderate leverage, while an interest coverage ratio of 234.29 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Infinitt Healthcare Co., Ltd posted a return on equity (ROE) of 21.48, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 9.09 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 16.62, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 20.61, useful for judging operating efficiency across full business cycles. The company generates approximately 435.74M in revenue per employee across its workforce of 252.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 27.39 indicates how many times Infinitt Healthcare Co., Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Infinitt Healthcare Co., Ltd recorded 8.57B in income tax expense. That works out to an effective tax rate of 17.23, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 49.72B, leaving 40.64B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Infinitt Healthcare Co., Ltd's stock has gained approximately 84.81% over the past 52 weeks. The 50-day moving average sits at 10,570.40, while the 200-day moving average is 7,885.20.

Over the twelve months ended March 31, 2026, Infinitt Healthcare Co., Ltd generated 110.02B in revenue and converted that into 40.64B in net income, yielding earnings per share of 1,688.12. EBITDA reached 23.11B, while operating income came in at 20.89B.

As of March 31, 2026, Infinitt Healthcare Co., Ltd holds 192.87B in cash and equivalents against 2.55B in total debt, resulting in a net debt position of -13.84B. Total book value stands at 201.95B, with working capital of 188.01B providing operational flexibility.

Infinitt Healthcare Co., Ltd produced 16.45B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -215.87M in capital expenditures, free cash flow totaled 16.24B - equivalent to 666.12 per share.

Over the twelve months ended March 31, 2026, Infinitt Healthcare Co., Ltd posted a gross margin of 64.65, reflecting its pricing power and cost economics. The operating margin of 18.99 and net profit margin of 36.94 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, Infinitt Healthcare Co., Ltd paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 11.18, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.77, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Infinitt Healthcare Co., Ltd shareholders.

As of March 31, 2026, Infinitt Healthcare Co., Ltd has an Altman Z-Score of 3.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.